CEO of Plus Therapeutics Simultaneously Vests RSUs While Off‑Loading Shares: A Sign of Long‑Term Commitment Amid Market Decline
Plus Therapeutics CEO’s recent RSU vesting and stock sales reveal a strategic balance of liquidity and long‑term confidence—insights investors need to gauge future upside.
4 minutes to read
